Queirolo, P;
Cinquini, M;
Argenziano, G;
Bassetto, F;
Bossi, P;
Boutros, A;
Clemente, C;
Del Vecchio, M;
Pennachioli, E;
Peris, K;
Quaglino, P;
Reali, A;
Zalaudek, I;
Spagnolo, F.
Cutaneous squamous cell carcinoma (CSCC) accounts for ∼20%-25% of all skin tumors. Its precise incidence is often challenging to determine due to limited statistics and its incorporation with mucosal forms. While most cases have a favorable prognosis, challenges arise in patients presenting with locall...
Pavlick, Anna C;
Ariyan, Charlotte E;
Buchbinder, Elizabeth I;
Davar, Diwakar;
Gibney, Geoffrey T;
Hamid, Omid;
Hieken, Tina J;
Izar, Benjamin;
Johnson, Douglas B;
Kulkarni, Rajan P;
Luke, Jason J;
Mitchell, Tara C;
Mooradian, Meghan J;
Rubin, Krista M;
Salama, April K. S;
Shirai, Keisuke;
Taube, Janis M;
Tawbi, Hussein A;
Tolley, J Keith;
Valdueza, Caressa;
Weiss, Sarah A;
Wong, Michael K;
Sullivan, Ryan J.
Since the first approval for immune checkpoint inhibitors
(ICIs) for the treatment of cutaneous melanoma more than
a decade ago, immunotherapy has completely transformed
the treatment landscape of this chemotherapy-resistant
disease. Combination regimens including ICIs directed
against programmed cell de...
Seth, Rahul;
Agarwala, Sanjiv S;
Messersmith, Hans;
Alluri, Krishna C;
Ascierto, Paolo A;
Atkins, Michael B;
Bollin, Kathryn;
Chacon, Matias;
Davis, Nancy;
Faries, Mark B;
Funchain, Pauline;
Gold, Jason S;
Guild, Samantha;
Gyorki, David E;
Kaur, Varinder;
Khushalani, Nikhil I;
Kirkwood, John M;
McQuade, Jennifer Leigh;
Meyers, Michael O;
Provenzano, Anthony;
Robert, Caroline;
Santinami, Mario;
Sehdev, Amikar;
Sondak, Vernon K;
Spurrier, Gilliosa;
Swami, Umang;
Truong, Thach-Giao;
Tsai, Katy K;
van Akkooi, Alexander;
Weber, Jeffrey.
To provide guidance to clinicians regarding the use of systemic therapy for melanoma.
American Society of Clinical Oncology convened an Expert Panel and conducted an updated systematic review of the literature.
The updated review identified 21 additional randomized trials.
Neoadjuvant pembrolizumab was n...
En el documento de alcance y objetivos se estableció como objetivo de la guía el aportar
indicaciones sobre aspectos controvertidos del diagnóstico, los tratamientos médicos y
quirúrgicos y el seguimiento de estos pacientes (material suplementario-apartado 2). El ámbito
asistencial de la GPC es la ...
Generar recomendaciones basadas en la mejor evidencia disponible acerca del manejo de personas
con cáncer de ovario....
